The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality
- PMID: 17259870
- DOI: 10.1097/01.inf.0000253053.01151.bd
The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality
Abstract
Background: Two systematic reviews evaluating influenza vaccine efficacy in healthy children have recently been published. Although quantitative summary estimates were similar, authors' conclusions were quite contrasting. We carried out another meta-analysis reevaluating study inclusion criteria and using metaregression techniques in addition to sensitivity and subgroups analyses to evaluate potential sources of heterogeneity of efficacy estimates, including methodologic quality of studies.
Methods: Only randomized clinical studies assessing the efficacy of influenza vaccine in healthy children/adolescents (age < or =18 years) for preventing naturally occurring influenza and/or acute otitis media cases were included. Summary estimates of effect were obtained using a random effects model. The methodologic quality of each study was assessed using 3 systems: Chalmers scale, Jadad scale and Schulz components (randomization, allocation concealment and double-blinding).
Results: The overall vaccination efficacy was 36% (95% confidence interval: 31-40%) against clinically diagnosed illnesses (evaluated by 19 randomized clinical studies for a total of 247,517 children); 67% (51-78%) against laboratory-confirmed cases (18 trials, n = 8574); and 51% (21-70%) against acute otitis media (11 trials, n = 11,349). Significant sources of between-study heterogeneity were participants' age and study quality both directly correlated with the efficacy. When the analysis was performed excluding USSR studies, the overall efficacy of the vaccine in preventing clinical cases substantially increased (from 36% to 61%).
Conclusions: These findings may indicate that the vaccine efficacy might be greater than the overall estimates. Although no safety and cost considerations are addressed in this analysis, the present findings support vaccination as a possible option for the prevention of influenza in healthy children and adolescents.
Similar articles
-
Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis.Vaccine. 2004 Sep 3;22(25-26):3475-86. doi: 10.1016/j.vaccine.2004.01.068. Vaccine. 2004. PMID: 15308375
-
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.Pediatr Infect Dis J. 2004 Feb;23(2):138-44. doi: 10.1097/01.inf.0000109392.96411.4f. Pediatr Infect Dis J. 2004. PMID: 14872180 Clinical Trial.
-
Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.Pediatrics. 2006 Dec;118(6):2298-312. doi: 10.1542/peds.2006-0725. Pediatrics. 2006. PMID: 17142512 Clinical Trial.
-
Trivalent intranasal influenza vaccine, live.Ann Pharmacother. 2004 Dec;38(12):2086-93. doi: 10.1345/aph.1E191. Epub 2004 Oct 19. Ann Pharmacother. 2004. PMID: 15494383 Review.
-
Cold-adapted, live attenuated influenza vaccine.Expert Rev Vaccines. 2004 Apr;3(2):131-9. doi: 10.1586/14760584.3.2.131. Expert Rev Vaccines. 2004. PMID: 15056039 Review.
Cited by
-
Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine.Vaccines (Basel). 2024 Jan 29;12(2):136. doi: 10.3390/vaccines12020136. Vaccines (Basel). 2024. PMID: 38400120 Free PMC article.
-
Grandmother presence improved grandchild survival against childhood infections but not vaccination coverage in historical Finns.Proc Biol Sci. 2023 May 31;290(1999):20230690. doi: 10.1098/rspb.2023.0690. Epub 2023 May 31. Proc Biol Sci. 2023. PMID: 37253424 Free PMC article.
-
A conserved multi-epitope-based vaccine designed by targeting hemagglutinin protein of highly pathogenic avian H5 influenza viruses.3 Biotech. 2020 Dec;10(12):546. doi: 10.1007/s13205-020-02544-3. Epub 2020 Nov 23. 3 Biotech. 2020. PMID: 33251084 Free PMC article.
-
Impact of Vaccines; Health, Economic and Social Perspectives.Front Microbiol. 2020 Jul 14;11:1526. doi: 10.3389/fmicb.2020.01526. eCollection 2020. Front Microbiol. 2020. PMID: 32760367 Free PMC article. Review.
-
Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).Can Commun Dis Rep. 2013 Oct 10;39(ACS-4):1-37. doi: 10.14745/ccdr.v39i00a04. eCollection 2013 Oct 10. Can Commun Dis Rep. 2013. PMID: 31701948 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
